Since gene expression in all patients was significantly higher than in healthy controls, the increased expression of CRB3 in HFRs compared with controls would also be expected, so that changes in the expression of this gene could be introduced as a predisposing factor for MS. This evidence concerns the gene CRB3 and myeloid sarcoma.